Upcoming Classes

Mpox continues to present challenges for clinicians despite declining public attention. In this webinar, Dr. Joseph Cherabie and Dr. Jason Zucker will provide an evidence-based review of current epidemiology, clinical presentation, diagnostic strategies, and management considerations for Mpox. Faculty will discuss recent trends in transmission, treatment protocols, and recommended approaches for prevention and patient counseling in diverse clinical settings.

Participants will gain practical guidance on recognizing atypical presentations and will also address current vaccination recommendations.

This activity is designed for physicians, advanced practice providers, nurses, and other clinical healthcare professionals involved in the diagnosis, management, or prevention of Mpox. 

AGENDA

Session:

·         Mpox Is Still Here: What Clinicians Need to Know

Speakers:

         ·     Jason Zucker, MD, MS,
          Assistant Medical Director, New York City STI/HIV Prevention Training Center; Assistant Professor of Medicine, Columbia University Medical Center

·    Joseph Cherabie, MD, MSc, Medical Director, St. Louis STI/HIV Prevention Training Center

Time:

                     ·   1:00 – 2:15 pm PT /       

                     ·   2:00 – 3:15 pm MT/

                     ·   3:00 – 4:15 pm CT/

           ·  4:00 – 5:15 pm ET/

Learning Objectives

1. Describe current STI/HIV screening strategies including diagnostic algorithms.
2. Describe current STI/HIV treatment recommendations.
3. Describe current STI/HIV clinical management for patients and their partners.
4. Describe the importance of interprofessional collaboration in sexual health care.

This webinar is intended for physicians, nurse practitioners, nurses, physician assistants, and other health care professionals caring for patients' sexual health.

CME/CNE Accreditation

Participants can earn 1.0 NCPD contact hours for this live educational activity.

This nursing continuing professional development activity was approved by Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

The UAB Heersink School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Joint Provider Acknowledgement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the UAB Heersink School of Medicine and the NYC STI/HIV Prevention Training Center. The UAB Heersink School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. UAB is an Equal Opportunity/Affirmative Action Employer.

Financial Relationship Disclosures

Dr. Natalie Neu is a DSMB member for Melinta Pharmaceuticals. Dr. Joe Cherabie received a consulting fee from Roche and an honorarium from Innoviva. Both of Dr. Cherabie’s financial relationships have ended. All financial relationships have been mitigated. No relevant financial relationships were identified for any other individuals with the ability to control content of the activity. 

CE Instructions

To obtain a CE certificate for this activity, the learner must complete the following criteria:

• Attend at least 50 minutes of instruction time
• Complete and submit the short-term evaluation form online

Participants who successfully complete the above requirements will receive a CE certificate, which will be emailed to you later. While not required, we encourage participants to complete the long-term evaluation form to help the planning team evaluate the success of the course. 

STI Overview

OBJECTIVES 

1.  Describe most recent epidemiology for reportable STIs in the United States and locally

2.  Identify the common bacterial or antibiotic treated STIs

3.  Identify the common viral STIs

4.  Describe at least 2 population factors increasing one's risk for acquisition of an STI

5.  Discuss provider skills in sexual health services3.  Identify the common viral STIs

6.  Describe the importance of interprofessional collaboration in health department and

private practice regarding STIs

CME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Alabama Marnix E. Heersink School of Medicine and the STD/HIV Prevention Training Center at Johns Hopkins. The University of Alabama Heersink School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Alabama Heersink School of Medicine designates this live activity for a maximum of 16.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Shanna Dell would like to disclose that her agency gets money from Gilead Pharmaceuticals. Dr. Khalil Ghanem would like to disclose that he gets royalties from UpToDate.  Lee Gilman would like to disclose that he receives an honorarium from CME Outfitters.  All other speakers do not have anything to disclose

There is no commercial support for this activity. 

CNE

This nursing continuing Professional Development activity was approved by the Oregon Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

There are 16.5 nursing contact hours awarded for those who attend the entire program as well as complete the evaluation for this program.

Lee Gilman would like to disclose that he receives an honorarium from CME Outfitters.

None of the planners for this activity have relevant financial relationship(s) with ineligible companies to disclose.

 Screen, Diagnose, Treat: Responding to Syphilis in Oklahoma offers an overview of current syphilis trends and priority concerns across the state. Participants will learn screening, diagnostic, and treatment practices grounded in the latest evidence. This session provides practical guidance to help providers strengthen prevention efforts and improve patient outcomes. 

Learning Outcomes:

Participants will demonstrate increased knowledge and confidence in identifying, diagnosing, managing, and treating syphilis across various populations, thereby improving overall prevention and health outcomes in their communities.

Learning Objectives: 

• Describe the national and local epidemiology and trends of syphilis in Oklahoma.
• State the current recommendations for syphilis screening, including considerations for pregnant persons and other priority populations.
• Discuss evidence-based approaches for the diagnosis, management, and treatment of syphilis.
• Identify key strategies and action steps for healthcare providers to reduce syphilis transmission and improve linkage to care and treatment outcomes.

Date: December 11th, 2025

Time : 7:00AM-8:15AM CST

Location: Will be sent after registration in confirmation email. 

This 90-minute training explores the intersection of substance use disorders (SUD) and sexually transmitted infections (STIs) in Louisiana. Participants will gain insights into current trends in opioid, fentanyl, and methamphetamine use, and how these patterns influence STI risk and outcomes in Louisiana. The session highlights harm reduction strategies, community resources, as well as stigma reduction approaches for providers and frontline staff. A panel of will share perspectives from the field, including disease intervention specialists and harm reduction teams, equipping attendees with practical tools to address SUD and STI challenges in their communities.

Learning Objective

• Examine the intersection of substance use disorders (SUD) and sexually transmitted infections (STIs) in Louisiana, with emphasis on harm reduction, stigma reduction, and clinical/provider awareness.

Learning Outcomes

By the end of this training, participants will be able to:

1. Identify key factors contributing to the overlap between SUD and STI transmission, acquisition, and treatment within Louisiana.
2. Apply harm reduction strategies and community resources to better support individuals with SUD and reduce barriers to STI prevention and care.

STI Expert Hour Webinar - Male Partner Treatment to Prevent BV Recurrence: Evidence and Implementation

December 18, 2025

1:30p.m. - 2:50p.m.

1.25 CME units at no cost

Registration closes on December 17, 2025 at 3:00PM (PST).

Presenter

Catriona Bradshaw, MMBS(Hons), FAChSHM, FAHMS, PhD

Professor

Melbourne Sexual Health Centre, Alfred Health

School of Translational Medicine, Monash University

Melbourne School of Population and Global Health, University of Melbourne

Course Description

This seminar will discuss the epidemiological and microbiological evidence and pilot data that led to the StepUp randomised controlled trial (RCT) - an RCT that demonstrated treating male partners with a combination of oral and topical antimicrobials at the time a women is being treated for bacterial vaginosis (BV) significantly improved cure over 12 weeks. The trial methodology and findings will be presented in detail. The seminar will have a focus on the practicalities of implementation and prescribing including examples of free online resources available to assist clinicians in discussing and providing partner treatment for BV, consumer resources to assist informed decision making, and qualitative research findings. Time will be made available for audience discussion and participation. 

Learning Objectives

• Participants will be able to understand the rationale and evidence for male partner treatment for BV and apply this new knowledge to their clinical practice. 
• Participants will be able to discuss partner treatment for BV with their patients, facilitate shared decision making, understand where to access evidence-based resources, and make informed decisions regarding the provision of this intervention for heterosexual couples.

Registration Confirmation with Zoom Webinar Link

Within 24 hours of registering: 

• You will receive the NNPTC registration confirmation email from training@nnptc.org sent to the email you used to register with for the webinar on NNPTC.
• The registration confirmation email will include the Zoom webinar link.
• Please review the Zoom webinar link instructions and other webinar details prior to joining the webinar.
• We ask that you do not share or forward any links associated with the webinar.
• Those not registered on NNPTC who sign on to the webinar will not be counted in attendance or eligible to receive CME credit. 
• To ensure you receive the NNPTC registration confirmation, please add training@nnptc.org to your safe/trusted senders list and be sure to monitor both your Inbox and spam/junk folders for the notification.

ACCME Disclosure

This activity has been planned and implemented in accordance with accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Nevada, Reno School of Medicine and California Prevention Training Center. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education to physicians. The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses may receive continuing education credit for this educational activity as the ANCC accepts AMA PRA Category 1 Credits™ through its reciprocity agreement. Nurses should check with their individual licensing boards to confirm the acceptability of AMA credits for the purpose of licensing renewal.

Financial Disclosure

As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of a continuing medical education activity disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that neither they nor their spouse/legally recognized domestic partner has any financial relationships with commercial interests related to the content of this activity.

*This Course will take place on February 12, 2026 from 9AM - 12 PM CST

STI Update: Sex throughout the Generations

Target Audience:  Physicians, midlevel practitioners (PA, NP), nurses, and other health professionals who see patients with or at risk for sexually transmitted infections (STIs).

Course Description: Faculty and staff from the St. Louis STI/HIV Prevention Training Center will discuss the realities of providing sexual healthcare throughout the lifetime, starting at youth to our older patients. Including but not limited to: case discussion, treatment options, & innovative ideas on sexual healthcare.

The Virtual STD Intensive Course content includes review of epidemiology, clinical presentation, diagnosis, treatment, and management for bacterial (gonorrhea, chlamydia, and syphilis) and viral (HPV, HSV) sexually transmitted infections, HIV prevention, vaginitis and PID, and case management discussions.

 Each course is limited to 25-30 participants and is delivered via an interactive online platform over five days.

After completing this registration form, you will be contacted by a member of the Denver PTC staff for a brief interview to determine course eligibility. You will then be given an access code to complete the registration process. You are not registered for this course unless you have received a confirmation that the registration process is complete.

*CE will be provided but is currently pending approval. 

*This course is on March 12 & 13 from 8AM-4:30PM CST both days.

Target Audience:  Physicians, midlevel practitioners (PA, NP), nurses, and other health professionals who see patients with or at risk for sexually transmitted infections (STIs).

Course Description:  This course, an intensive overview of STDs, includes 14 hours of lecture over two days.  Topics presented include gonorrhea, chlamydia, syphilis, trichomoniasis, PID, genital herpes, HPV, hepatitis B, chancroid, urethritis/cervicitis syndromes, pediculosis/ scabies, HIV/AIDS, prevention strategies / PrEP / EPT, and case studies.

Course Objectives:  At the end of this course, participants will be able to:

• Describe clinical features of reportable STDs: syphilis, gonorrhea, chlamydia.
• Understand current STD epidemiological patterns.
• Describe clinical features of common bacterial STDs:  syphilis, gonorrhea, chlamydia
• Recognize clinical presentations of common viral STDs:  genital herpes, HPV
• Demonstrate improved skills in completing STD history and physical exam.
• Discuss clinical characteristics of common vaginal infections:  trichomoniasis, bacterial vaginosis, candidiasis
• Integrate HIV risk assessment into patient care.
• Demonstrate universal precautions during specimen collection.
• Describe current approaches to STD/HIV prevention including pre-exposure prophylaxis and expedited partner therapy.
• Discuss evidence-based strategies for STD treatment, according to CDC’s STD Treatment Guidelines.